Form 4: Heartflow CEO John Farquhar Reports Stock Tax Withholding

CEO John Farquhar disposed of 7,204 shares of Heartflow common stock to satisfy tax obligations related to RSU vesting.

Summary

• John C.M. Farquhar, CEO of Heartflow, Inc., executed two transactions involving the disposal of common stock.
• On May 6, 2026, 5,300 shares were withheld at a price of $30.29.
• On May 7, 2026, 1,904 shares were withheld at a price of $29.98.
• The total of 7,204 shares were retained by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the share disposal is purely for tax compliance and does not reflect a change in the executive's outlook on the company.

Positives

• The transactions were routine administrative actions related to tax obligations rather than discretionary market sales.

Negatives

• The reporting person's direct beneficial ownership decreased from 549,163 shares to 541,959 shares following these transactions.

Risks

• None identified; this is a standard regulatory disclosure for executive compensation tax compliance.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a standard administrative disclosure common in the medical technology sector, where equity-based compensation is a primary component of executive remuneration packages.

Comparison to Industry Standards

• The transaction follows standard industry practice for net settlement of equity awards to cover tax liabilities.
• The behavior is consistent with typical executive ownership management at peer medical device companies.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a non-discretionary tax settlement.

Key Dates

Keywords

Heartflow, HTFL, Insider Trading, Form 4, Executive Compensation, Tax Withholding